Special Notice Notice of Intent to Award a Sole Source Procurement The Department of Veterans Affairs, Veterans Health Administration, Network Contracting Office 17, intends to award a firm-fixed priced contract to Roche Diagnostics Corporation for procurement of the following reagents and consumable supplies: Estimated Annual Quantities Item Description Item Number Quantity Reagent, DAB Detection 760-500 20 Reagent, Stainer, Amplification 760-080 18 Reagent, Stainer, Reaction Buffer 950-300 40 Reagent, Antibody, DIL, BUFF 251-018 4 Reagent, Hematoxylin 760-2021 24 Bluing Agent 760-2037 24 Staining Solution, Protease 760-2018 5 Stainer, Prep Solution 950-102 12 Solution, Ultra 650-210 68 Solution, Ultra, Cell CC1 950-224 12 Control, Negative 760-1029 6 Elastin Staining Kit, Simple Stain 860-005 3 Staining Kit, Complex Stains, Reticulum II 860-024 4 Staining Kit, Complex Stains, Special 860-028 4 Staining Kit, Complex Stains, Jones 860-019 3 DEPAR Solution, BMK Special Stains 860-036 10 Liquid Coverslip, BMK Special Stains 860-034 24 Wash Solution, BMK Special Stains 860-035 12 Special Stains Clean Plus 860-037 12 Special Stains Cleaning Kit 860-016 12 Dispenser, Antibody-H-Pylori-Polyclonal 790-1014 16 Reagent, Flow Cytometry, TTF-1, Clone 790-4398 8 Ribbon, Printer 1632900 6 Label, Bar Code 1418702 4 Reagent, Stainer, Keratin 7 790-4462 8 Antibody KI 67 790-4286 6 Antibody S100 Primary 760-2523 6 Dispenser, Antibody-CK5/6 790-4554 10 Reagent, Stainer, Keratin 20 790-4431 6 The requested items will be used on the Ventana BenchMark Ultra system. The requesting activity states that the government owns and operates a Ventana BenchMark Ultra System and that the requested reagents and consumable supplies are the only supplies compatible with the instrument. A sole source letter from Roche states that all Ventana detection reagents, ancillaries, antibodies and probes are developed and validated for exclusive use on the fully automated Ventana Benchmark IHC/ISH slide staining system and cannot be substituted. The proposed order will be considered a standing order; where, the supplies will be ordered throughout the period of performance, on an as-needed basis. Network Contracting Office 17 will request the acquisition of these supplies from Roche on an IDIQ contract with a five-year ordering period. This notice is not to be considered a request for quotations or proposals. A contract will not be awarded based on an offer received in response to this notice; however, all responsible sources may submit a capability statement, proposal or quotation, which shall be considered by the agency. Proposals or offers received will be used to determine if a comparable source is available and more advantageous to the government. If no affirmative written response is received within 5 days from the publication of this notice, a contract/order will be issued to Roche Diagnostics Corporation without any further notice. The proposed contract actions are for supplies, which the government intends to negotiate with only one source. The anticipated statutory authorities permitting other than full and open competition for the requirement is 41 U.S.C. 3304(a)(1), as implemented by FAR 6.302-1, Only one responsible source and no other supplies or services will satisfy agency requirements. The proposed sole source procurement will be made by an open market pricing agreement with Roche Diagnostics Corporation.

Bid Protests Not Available